retatrutide clinical data retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial A new weight-loss drug called
Description
Cognitive and behavioral problems might also manifest
Future studies will also be needed to test whether the effects of GLP-1 effects on aging biology are enhanced when combined with lifestyle interventions such as diet, exercise and sleep optimization
Treatment Response Monitoring and Outcome Assessment Systematic monitoring of treatment response requires standardized assessment protocols tracking both subjective and objective neurological parameters
The enhanced regulations instruct physicians to obtain a proper medical history and discourage prescriptions on the first visit
Subramaniam SR, Chesselet MF
Endocrinology 111:16011606
